InnovAge Holding (INNV) Receives a Hold from J.P. Morgan

In a report released yesterday, Lisa Gill from J.P. Morgan maintained a Hold rating on InnovAge Holding (INNVResearch Report), with a price target of $5.00. The company’s shares closed last Thursday at $4.56, close to its 52-week low of $3.46.

According to, Gill is a 5-star analyst with an average return of 16.0% and a 61.7% success rate. Gill covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Alignment Healthcare, and Bright Health Group.

Currently, the analyst consensus on InnovAge Holding is a Hold with an average price target of $5.92.

See the top stocks recommended by analysts >>

The company has a one-year high of $27.18 and a one-year low of $3.46. Currently, InnovAge Holding has an average volume of 815.2K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes.

Read More on INNV:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More